# Provident Financial Services Inc: financial statements, quarterly

PFS · NYSE · CIK 1178970 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/pfs.md) · [Financials](/companies/pfs/financials.md) · [Filings](/companies/pfs/filings.md) · [Insiders](/companies/pfs/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/pfs/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [14.2](/filings/0001628280-24-046304.md) | [13.7 d](/filings/0001628280-26-012814.md) | [16.3](/filings/0001628280-25-023612.md) | [17.6](/filings/0001628280-25-038814.md) | [17.9](/filings/0001628280-25-050020.md) | [16.5 d](/filings/0001628280-26-012814.md) | [18.9](/filings/0001628280-26-032754.md) | [18.3](/filings/0001628280-26-054777.md) | [17.7](/filings/0001628280-25-050020.md) | [18.0 d](/filings/0001628280-26-012814.md) | [20.6](/filings/0001628280-26-032754.md) | [19.6](/filings/0001628280-26-054777.md) |
| Interest expense | $m | [62.0](/filings/0001628280-23-037940.md) | [68.4 d](/filings/0001628280-24-007678.md) | [70.2](/filings/0001628280-24-018502.md) | [106](/filings/0001628280-24-036015.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [8.8](/filings/0001628280-24-046304.md) | [12.5 d](/filings/0001628280-26-012814.md) | [10.9](/filings/0001628280-25-023612.md) | [(9.8)](/filings/0001628280-25-038814.md) | [18.9](/filings/0001628280-25-050020.md) | [14.2 d](/filings/0001628280-26-012814.md) | [27.8](/filings/0001628280-26-032754.md) | [30.5](/filings/0001628280-26-054777.md) | [29.9](/filings/0001628280-25-050020.md) | [28.8 d](/filings/0001628280-26-012814.md) | [30.8](/filings/0001628280-26-032754.md) | [27.9](/filings/0001628280-26-054777.md) |
| Net income | $m | [28.5](/filings/0001628280-24-046304.md) | [27.3 d](/filings/0001628280-26-012814.md) | [32.1](/filings/0001628280-25-023612.md) | [(11.5)](/filings/0001628280-25-038814.md) | [46.4](/filings/0001628280-25-050020.md) | [48.5 d](/filings/0001628280-26-012814.md) | [64.0](/filings/0001628280-26-032754.md) | [72.0](/filings/0001628280-26-054777.md) | [71.7](/filings/0001628280-25-050020.md) | [83.4 d](/filings/0001628280-26-012814.md) | [79.4](/filings/0001628280-26-032754.md) | [78.1](/filings/0001628280-26-054777.md) |
| Diluted EPS | $ per share | [0.38](/filings/0001628280-24-046304.md) | not reported | [0.43](/filings/0001628280-25-023612.md) | [(0.11)](/filings/0001628280-25-038814.md) | [0.36](/filings/0001628280-25-050020.md) | not reported | [0.49](/filings/0001628280-26-032754.md) | [0.55](/filings/0001628280-26-054777.md) | [0.55](/filings/0001628280-25-050020.md) | not reported | [0.61](/filings/0001628280-26-032754.md) | [0.60](/filings/0001628280-26-054777.md) |
| Basic EPS | $ per share | [0.38](/filings/0001628280-24-046304.md) | not reported | [0.43](/filings/0001628280-25-023612.md) | [(0.11)](/filings/0001628280-25-038814.md) | [0.36](/filings/0001628280-25-050020.md) | not reported | [0.49](/filings/0001628280-26-032754.md) | [0.55](/filings/0001628280-26-054777.md) | [0.55](/filings/0001628280-25-050020.md) | not reported | [0.61](/filings/0001628280-26-032754.md) | [0.60](/filings/0001628280-26-054777.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [0.2](/filings/0001628280-24-046304.md) | [0.2](/filings/0001628280-26-012814.md) | [0.2](/filings/0001628280-25-023612.md) | [0.3](/filings/0001628280-25-038814.md) | [0.2](/filings/0001628280-25-050020.md) | [0.2](/filings/0001628280-26-054777.md) | [0.2](/filings/0001628280-26-032754.md) | [0.3](/filings/0001628280-26-054777.md) | [0.3](/filings/0001628280-25-050020.md) | [0.2](/filings/0001628280-26-054777.md) | [0.2](/filings/0001628280-26-032754.md) | [0.2](/filings/0001628280-26-054777.md) |
| Total assets | $bn | [14.1](/filings/0001628280-23-037940.md) | [14.2](/filings/0001628280-25-008991.md) | [14.1](/filings/0001628280-24-018502.md) | [24.1](/filings/0001628280-24-036015.md) | [24.0](/filings/0001628280-24-046304.md) | [24.1](/filings/0001628280-26-012814.md) | [24.2](/filings/0001628280-25-023612.md) | [24.5](/filings/0001628280-25-038814.md) | [24.8](/filings/0001628280-25-050020.md) | [25.0](/filings/0001628280-26-054777.md) | [25.2](/filings/0001628280-26-032754.md) | [25.7](/filings/0001628280-26-054777.md) |
| Total liabilities | $bn | [12.5](/filings/0001628280-23-037940.md) | [12.5](/filings/0001628280-25-008991.md) | [12.4](/filings/0001628280-24-018502.md) | [21.5](/filings/0001628280-24-036015.md) | [21.4](/filings/0001628280-24-046304.md) | [21.5](/filings/0001628280-26-012814.md) | [21.6](/filings/0001628280-25-023612.md) | [21.8](/filings/0001628280-25-038814.md) | [22.1](/filings/0001628280-25-050020.md) | [22.1](/filings/0001628280-26-054777.md) | [22.3](/filings/0001628280-26-032754.md) | [22.8](/filings/0001628280-26-054777.md) |
| Shareholders' equity | $bn | [1.6](/filings/0001628280-24-046304.md) | [1.7](/filings/0001628280-26-012814.md) | [1.7](/filings/0001628280-25-038814.md) | [2.6](/filings/0001628280-25-050020.md) | [2.6](/filings/0001628280-25-050020.md) | [2.6](/filings/0001628280-26-054777.md) | [2.7](/filings/0001628280-26-054777.md) | [2.7](/filings/0001628280-26-054777.md) | [2.8](/filings/0001628280-25-050020.md) | [2.8](/filings/0001628280-26-054777.md) | [2.9](/filings/0001628280-26-054777.md) | [2.9](/filings/0001628280-26-054777.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [41.7 d](/filings/0001628280-24-046304.md) | [46.3 d](/filings/0001628280-26-012814.md) | [41.4](/filings/0001628280-25-023612.md) | [76.5 d](/filings/0001628280-25-038814.md) | [69.2 d](/filings/0001628280-25-050020.md) | [239 d](/filings/0001628280-26-012814.md) | [88.5](/filings/0001628280-26-032754.md) | [187 d](/filings/0001628280-26-054777.md) | [98.0 d](/filings/0001628280-25-050020.md) | [68.9 d](/filings/0001628280-26-012814.md) | [84.7](/filings/0001628280-26-032754.md) | [119 d](/filings/0001628280-26-054777.md) |
| Capital expenditure | $m | [2.9 d](/filings/0001628280-24-046304.md) | [1.6 d](/filings/0001628280-26-012814.md) | [0.5](/filings/0001628280-25-023612.md) | [1.0 d](/filings/0001628280-25-038814.md) | [1.3 d](/filings/0001628280-25-050020.md) | [(1.5) d](/filings/0001628280-26-012814.md) | [1.1](/filings/0001628280-26-032754.md) | [4.2 d](/filings/0001628280-26-054777.md) | [1.3 d](/filings/0001628280-25-050020.md) | [4.9 d](/filings/0001628280-26-012814.md) | [3.7](/filings/0001628280-26-032754.md) | [10.2 d](/filings/0001628280-26-054777.md) |
| Dividends paid | $m | [18.1 d](/filings/0001628280-24-046304.md) | [17.6 d](/filings/0001628280-26-012814.md) | [18.1](/filings/0001628280-25-023612.md) | [19.0 d](/filings/0001628280-25-038814.md) | [31.4 d](/filings/0001628280-25-050020.md) | [32.4 d](/filings/0001628280-26-012814.md) | [31.9](/filings/0001628280-26-032754.md) | [31.3 d](/filings/0001628280-26-054777.md) | [31.3 d](/filings/0001628280-25-050020.md) | [31.3 d](/filings/0001628280-26-012814.md) | [31.4](/filings/0001628280-26-032754.md) | [30.4 d](/filings/0001628280-26-054777.md) |
| Share repurchases | $m | [0.0 d](/filings/0001628280-23-037940.md) | [0.0 d](/filings/0001628280-26-012814.md) | not reported | not reported | not reported | not reported | [0.0](/filings/0001628280-26-032754.md) | [0.0 d](/filings/0001628280-26-054777.md) | not reported | not reported | [10.3](/filings/0001628280-26-032754.md) | [0.0 d](/filings/0001628280-26-054777.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividends
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [74.4](/filings/0001628280-23-037940.md) | [74.7](/filings/0001628280-24-018502.md) | [74.8](/filings/0001628280-24-036015.md) | [74.9](/filings/0001628280-24-046304.md) | [75.3](/filings/0001628280-25-023612.md) | [103](/filings/0001628280-25-038814.md) | [130](/filings/0001628280-25-050020.md) | [130](/filings/0001628280-26-032754.md) | [131](/filings/0001628280-26-054777.md) | [131](/filings/0001628280-25-050020.md) | [131](/filings/0001628280-26-032754.md) | [130](/filings/0001628280-26-054777.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 130,422,618 at 2026-08-03, from the cover of the [10-Q filed 2026-08-07](/filings/0001628280-26-054777.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:35 ET. No prices; not investment advice.